Richard K. Sterling

29.9k total citations · 8 hit papers
326 papers, 20.6k citations indexed

About

Richard K. Sterling is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Richard K. Sterling has authored 326 papers receiving a total of 20.6k indexed citations (citations by other indexed papers that have themselves been cited), including 259 papers in Hepatology, 241 papers in Epidemiology and 56 papers in Surgery. Recurrent topics in Richard K. Sterling's work include Liver Disease Diagnosis and Treatment (211 papers), Hepatitis C virus research (153 papers) and Liver Disease and Transplantation (138 papers). Richard K. Sterling is often cited by papers focused on Liver Disease Diagnosis and Treatment (211 papers), Hepatitis C virus research (153 papers) and Liver Disease and Transplantation (138 papers). Richard K. Sterling collaborates with scholars based in United States, Canada and United Kingdom. Richard K. Sterling's co-authors include Arun J. Sanyal, Velimir A. Luketic, Mitchell L. Shiffman, Melissa J. Contos, Robert A. Fisher, Mark Sulkowski, Ricard Solà, Diethelm Messinger, Eduardo Lissen and David L. Thomas and has published in prestigious journals such as Journal of Clinical Investigation, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Richard K. Sterling

309 papers receiving 20.1k citations

Hit Papers

Development of a simple noninvasive index to predict sign... 2001 2026 2009 2017 2006 2001 2003 2009 2019 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
    2006 3.5k citations Richard K. Sterling, Mark Sulkowski et al. Hepatology profile →
  2. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
    2001 1.7k citations Arun J. Sanyal, Richard K. Sterling et al. Gastroenterology profile →
  3. Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt Values
    2003 909 citations Velimir A. Luketic, Richard K. Sterling et al. Hepatology profile →
  4. The plasma lipidomic signature of nonalcoholic steatohepatitis†‡
    2009 521 citations Prem Puri, Richard K. Sterling et al. Hepatology profile →
  5. Increased Risk for Hepatocellular Carcinoma Persists Up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
    2019 233 citations Richard K. Sterling, David E. Kaplan et al. Gastroenterology profile →
  6. AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
    2024 63 citations Richard K. Sterling, Andrés Duarte‐Rojo et al. Hepatology profile →
  7. AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
    2024 44 citations Richard K. Sterling, Keyur Patel et al. Hepatology profile →
  8. Microbiota transplant for hepatic encephalopathy in cirrhosis: The THEMATIC trial
    2025 16 citations Jasmohan S. Bajaj, Edith Gavis et al. Journal of Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard K. Sterling United States 66 15.8k 13.7k 4.4k 2.9k 2.1k 326 20.6k
Emmanuel Tsochatzis United Kingdom 55 12.1k 0.8× 9.4k 0.7× 3.4k 0.8× 2.5k 0.9× 1.4k 0.7× 308 15.8k
Manuel Romero‐Gómez Spain 55 11.1k 0.7× 8.0k 0.6× 2.5k 0.6× 3.0k 1.0× 1.5k 0.7× 375 14.7k
Velimir A. Luketic United States 58 10.5k 0.7× 9.1k 0.7× 4.7k 1.1× 2.3k 0.8× 1.5k 0.7× 176 14.2k
Vlad Ratziu France 75 22.6k 1.4× 14.3k 1.0× 3.1k 0.7× 7.1k 2.4× 2.6k 1.3× 337 25.6k
Michael Charlton United States 69 19.5k 1.2× 12.9k 0.9× 5.4k 1.2× 6.2k 2.2× 3.1k 1.5× 250 25.3k
Mauro Bernardi Italy 67 12.4k 0.8× 14.4k 1.1× 5.9k 1.3× 913 0.3× 1.4k 0.7× 346 19.6k
Jacob George Australia 52 11.6k 0.7× 6.4k 0.5× 1.9k 0.4× 4.1k 1.4× 2.0k 1.0× 275 15.4k
Kris V. Kowdley United States 86 20.1k 1.3× 14.5k 1.1× 5.6k 1.3× 5.1k 1.8× 3.2k 1.5× 451 29.4k
Richard Moreau France 77 14.3k 0.9× 16.3k 1.2× 7.4k 1.7× 782 0.3× 2.1k 1.0× 383 22.4k
Elizabeth E. Powell Australia 49 9.3k 0.6× 6.6k 0.5× 1.9k 0.4× 2.5k 0.9× 1.8k 0.9× 213 13.8k

Countries citing papers authored by Richard K. Sterling

Since Specialization
Citations

This map shows the geographic impact of Richard K. Sterling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard K. Sterling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard K. Sterling more than expected).

Fields of papers citing papers by Richard K. Sterling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard K. Sterling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard K. Sterling. The network helps show where Richard K. Sterling may publish in the future.

Co-authorship network of co-authors of Richard K. Sterling

This figure shows the co-authorship network connecting the top 25 collaborators of Richard K. Sterling. A scholar is included among the top collaborators of Richard K. Sterling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard K. Sterling. Richard K. Sterling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Phipps, Lisa, et al.. (2025). The changing demographics and severity in hospitalized patients across COVID-19 variants: A national cohort study. Journal of Clinical and Translational Science. 9(1). e22–e22. 1 indexed citations
2.
Anderson, Mark, Gavin Cloherty, Hyon S. Hwang, et al.. (2025). Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment. Journal of Clinical Investigation. 135(6). 1 indexed citations
3.
Patel, Nilang, Brian Davis, Richard K. Sterling, et al.. (2025). Use of Natural Language Processing to Objectively Identify Hepatic Encephalopathy in Multiple Cohorts. The American Journal of Gastroenterology.
4.
Allende, Daniela, Oscar W. Cummings, Cynthia Behling, et al.. (2024). MASLD in people with HIV exhibits higher fibrosis stage despite lower disease activity than in matched controls. Alimentary Pharmacology & Therapeutics. 60(10). 1351–1360. 3 indexed citations
5.
Rockey, Don C., Mouaz Alsawas, Andrés Duarte‐Rojo, et al.. (2024). Noninvasive liver disease assessment to identify portal hypertension: Systematic and narrative reviews supporting the AASLD Practice Guideline. Hepatology. 81(3). 1086–1104. 11 indexed citations
6.
Epstein, Rachel, Lynn E. Taylor, Jordan J. Feld, et al.. (2024). Clinical- and Cost-Effectiveness of Liver Disease Staging in Hepatitis C Virus Infection: A Microsimulation Study. Clinical Infectious Diseases. 80(2). 300–313. 1 indexed citations
7.
8.
Sterling, Richard K., Eduardo Vilar‐Gómez, Laura Wilson, et al.. (2024). Diagnostic Ability of Simple Noninvasive Blood Tests to Predict Increased Liver Stiffness in People Living With HIV and Steatotic Liver Disease. The American Journal of Gastroenterology. 119(8). 1483–1495. 2 indexed citations
9.
Terrault, Norah A., Anna S. Lok, Abdus S. Wahed, et al.. (2022). Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B. The American Journal of Gastroenterology. 118(7). 1214–1225. 11 indexed citations
10.
Fagan, Andrew, Edith Gavis, Brian Davis, et al.. (2022). A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study. Journal of Hepatology. 78(2). 312–321. 39 indexed citations
11.
Chung, Raymond, Wendy C. King, Marc G. Ghany, et al.. (2021). A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection. Clinical Gastroenterology and Hepatology. 21(1). 125–135.e8. 3 indexed citations
12.
Bajaj, Jasmohan S., Nita H. Salzman, Chathur Acharya, et al.. (2019). Fecal Microbial Transplant Capsules Are Safe in Hepatic Encephalopathy: A Phase 1, Randomized, Placebo‐Controlled Trial. Hepatology. 70(5). 1690–1703. 226 indexed citations
13.
Chang, Kyong‐Mi, Daniel Traum, Jang‐June Park, et al.. (2019). Distinct phenotype and function of circulating Vδ1+ and Vδ2+ γδT-cells in acute and chronic hepatitis B. PLoS Pathogens. 15(4). e1007715–e1007715. 24 indexed citations
14.
Siddiqui, Mohammad, Mohammad Siddiqui, Samarth Patel, et al.. (2019). Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients. Transplantation Proceedings. 51(6). 1895–1901. 9 indexed citations
15.
16.
Sterling, Richard K., Carolyn Driscoll, Scott Matherly, et al.. (2018). Treatment of HCV in the Department of Corrections in the Era of Oral Medications. Journal of Correctional Health Care. 24(2). 127–136. 30 indexed citations
17.
Lee, Laurie A., et al.. (2014). Growth Velocity Reduced with Once-Daily Fluticasone Furoate Nasal Spray in Prepubescent Children with Perennial Allergic Rhinitis. The Journal of Allergy and Clinical Immunology In Practice. 2(4). 421–427. 29 indexed citations
18.
Stravitz, R. Todd, Ton Lisman, Velimir A. Luketic, et al.. (2010). ACUTE LIVER INJURY/FAILURE (ALI/ALF) RESULTS IN BALANCED HEMOSTASIS DESPITE ELEVATED INR. Hepatology. 52(4). 1 indexed citations
19.
Lok, Anna S., Leonard B. Seeff, Timothy R. Morgan, et al.. (2008). Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease. Gastroenterology. 136(1). 138–148. 452 indexed citations
20.
Sterling, Richard K.. (2003). Guest Commentary: Why Writing Matters. Voices from the Middle. 11(2). 5–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Tsochatzis Breakdown of academic impact, for papers by Manuel Romero‐Gómez Breakdown of academic impact, for papers by Velimir A. Luketic Breakdown of academic impact, for papers by Vlad Ratziu Breakdown of academic impact, for papers by Michael Charlton Breakdown of academic impact, for papers by Mauro Bernardi Breakdown of academic impact, for papers by Jacob George Breakdown of academic impact, for papers by Kris V. Kowdley Breakdown of academic impact, for papers by Richard Moreau Breakdown of academic impact, for papers by Elizabeth E. Powell
Rankless by CCL
2026